Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Søndergaard, AL"'
Autor:
Rodbard, HW, Rosenstock, J, Canani, LH, Deerochanawong, C, Gumprecht, J5, Lindberg, SØ, Lingvay, I, Søndergaard, AL, Treppendahl, MB, Montanya, E, Cruz, P, Loredo, L, Luquez, C, Moisello, M, Augusto, GA, Castro, M, Canani, L, Akrap, Branko, Bulum, Tomislav, Rahelić, Dario, Šunić-Grčić, Ivana, Tušek, Srećko, Avramidis, I, Benroubi, M, Didangelos, T, Karousos, G, Pagkalos, E, Sampanis, C, Somali, M, Domboróczki, Z, Faludi, P, Gaál, Z, Kis- Gombos, P, Kocsis, G, Marton, Z, Sudár, Z, Buscemi, S, Di Carlo, A, Dotta, F, Gambineri, A, Lauro, D, Maranghi, M, Arciszewska, M, Gumprecht, J, Matuszewska, K, Skokowska, E, Stasinska, T, Feofanova, S, Filippova, E, Galstyan, G, Gaysina, L, Kunitsyna, M, Suplotova, L, Antic, S, Djukic, A, Mitrovic, M, Pesic, M, Stokic, E, Jodar, E, Martínez, E, Raya, PM, Portillo, CM, Vera, MP, Fernández, MR, San Jose, P, Riera, MT, Boonyavarakul, A, Sriwijitkamol, A, Ajani, D, Armas, E, Barbel- Johnson, K, Bartilucci, D, Bonabi, G, Busch, R, Butuk, D, Cannon, K, Chase, C, Chaykin, L, Cheekati, V, Davis, T, Delgado, B, Farris, N, Graves, M, Ha, C, Harper, L, Herring, S, Hewitt, M, Hsia, D, Jackson, R, Jardula, M, Joyce, M, Juarez, M, Kapoor, A, Karounos, D, Kayne, D, Lacour, A, Ledesma, G, Lipetz, R, Lomboy, J, Lynd, S, Morawski, E, Morin, R, Murphy, R, Overcash, JS, Pullman, J, Ruoff, G, Steenkamp, D, Toro, H, Trachtenbarg, D, Tulloch, B, Weisbrot, A, Wright, A.
OBJECTIVE Efficacy and safety of the glucagon-like peptide 1 (GLP-1) analog oral semaglutide and the sodium–glucose cotransporter 2 inhibitor empagliflozin were compared in patients with type 2 diabetes uncontrolled on metformin. RESEARCH DESIGN AN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11d426d2138bca66de639b58bfb9884d
https://doi.org/10.2337/dc19-0883
https://doi.org/10.2337/dc19-0883
Autor:
Koren MJ; Jacksonville Center for Clinical Research, Jacksonville, FL, USA. Electronic address: mkoren@encoredocs.com., Descamps O; Department of Internal Medicine, Pôle Hospitalier Jolimont, Réseau HELORA, Bruxelles, Belgium., Hata Y; Department of Cardiology, Minamino Cardiovascular Hospital, Hachioji, Japan., Hengeveld EM; Novo Nordisk, Søborg, Denmark., Hovingh GK; Novo Nordisk, Søborg, Denmark; Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, Netherlands., Ikonomidis I; Second Cardiology Department, Laboratory of Preventive Cardiology, Cardiometabolic Clinic, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, Chaidari, Greece., Radu Juul Jensen MD; Novo Nordisk, Søborg, Denmark., Langbakke IH; Novo Nordisk, Søborg, Denmark., Martens FMAC; Department of Cardiology, Heart Center, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Søndergaard AL; Novo Nordisk, Søborg, Denmark., Witkowski A; Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland., Koenig W; Deutsches Herzzentrum München, Technische Universität München, German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany; Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.
Publikováno v:
The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2024 Mar; Vol. 12 (3), pp. 174-183. Date of Electronic Publication: 2024 Feb 01.
Autor:
Frías JP; Clinical Research, National Research Institute, Los Angeles, CA, USA. Electronic address: juan.frias@nritrials.com., Auerbach P; Novo Nordisk, Søborg, Denmark., Bajaj HS; LMC Diabetes and Endocrinology, Brampton, ON, Canada., Fukushima Y; Fukuwa Clinic, Tokyo, Japan., Lingvay I; Department of Internal Medicine/Endocrinology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA., Macura S; Novo Nordisk, Søborg, Denmark., Søndergaard AL; Novo Nordisk, Søborg, Denmark., Tankova TI; Department of Endocrinology, Medical University of Sofia, Sofia, Bulgaria., Tentolouris N; Diabetes Centre, First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece., Buse JB; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Publikováno v:
The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2021 Sep; Vol. 9 (9), pp. 563-574. Date of Electronic Publication: 2021 Jul 21.
Autor:
Rodbard HW; Endocrine and Metabolic Consultants, Rockville, MD hrodbard@comcast.net., Rosenstock J; Dallas Diabetes Research Center at Medical City, Dallas, TX., Canani LH; Endocrine Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Deerochanawong C; Rajavithi Hospital, Rangsit Medical School, Bangkok, Thailand., Gumprecht J; Medical University of Silesia, Katowice, Poland., Lindberg SØ; Novo Nordisk A/S, Søborg, Denmark., Lingvay I; Departments of Internal Medicine and Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX., Søndergaard AL; Novo Nordisk A/S, Søborg, Denmark., Treppendahl MB; Novo Nordisk A/S, Søborg, Denmark., Montanya E
Publikováno v:
Diabetes care [Diabetes Care] 2019 Dec; Vol. 42 (12), pp. 2272-2281. Date of Electronic Publication: 2019 Sep 17.